Orient Pharma Co., Ltd. (TPEX:4166)
Taiwan · Delayed Price · Currency is TWD 25.15
+0.10 (0.40%)
Sep 8, 2026, 1:30 PM CST
Orient Pharma Market Cap
Orient Pharma has a market cap or net worth of 6.11 billion as of September 4, 2026. Its market cap has increased by 6.64% in one year.
Market Cap
6.11B
Enterprise Value
5.72B
Revenue
1.52B
Ranking
n/a
PE Ratio
25.70
Stock Price
25.15
ChartMarket Cap Chart
Since June 15, 2012, Orient Pharma's market cap has increased from 4.12B to 6.11B, an increase of 48.50%. That is a compound annual growth rate of 2.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 6.04B | 3.55% |
| Dec 31, 2025 | 5.83B | -27.36% |
| Dec 31, 2024 | 8.03B | 80.00% |
| Dec 29, 2023 | 4.46B | 14.13% |
| Dec 30, 2022 | 3.91B | 11.76% |
| Dec 30, 2021 | 3.50B | 28.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Foresee Pharmaceuticals | 12.60B |
| Standard Chemical & Pharmaceutical | 10.01B |
| SCI Pharmtech | 6.70B |
| Alar Pharmaceuticals | 6.14B |
| Formosa Laboratories | 5.45B |
| Panion & Bf Biotech | 4.83B |
| Yoda Pharmaceuticals | 4.57B |
| LIWANLI Innovation | 4.45B |